US2015218209A1PendingUtilityA1

Preparation and/or Purification of Oligonucleotide Conjugates

56
Assignee: SOLULINK INCPriority: Apr 18, 2007Filed: Sep 3, 2014Published: Aug 6, 2015
Est. expiryApr 18, 2027(~0.8 yrs left)· nominal 20-yr term from priority
C07K 16/44C07K 1/22C07K 2319/20C07K 2319/21C07K 2319/41C07K 2319/43A61K 47/6807A61K 47/6835
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods, systems and/or kits for the preparation, purification and isolation of oligonucleotide conjugates, comprising conjugation of modified antibodies or proteins with at least one modified oligonucleotide at greater than 80% efficiency to form oligonucleotide conjugates and isolating the oligonucleotide conjugates from the conjugation solution by binding the conjugates to an immobilized binder, wherein the binder may be a metal ion or an antibody.

Claims

exact text as granted — not AI-modified
1 . A method for isolating antibody-oligonucleotide conjugates, comprising:
 i) conjugating a modified antibody with at least one modified oligonucleotide to form antibody-oligonucleotide conjugates, wherein greater than 80% of the modified antibodies are conjugated;   ii) adding the conjugation reaction mixture to a column having a stationary phase comprising a binder that has been immobilized to the stationary phase;   iii) binding the antibody-oligonucleotide conjugates selectively to the immobilized binder;   iv) eluting reaction components away from the bound antibody-oligonucleotide conjugates; and   v) isolating the antibody-oligonucleotide conjugates by releasing the bound antibody-oligonucleotide conjugates with a displacing agent selective for the binder.   
     
     
         2 - 57 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.